Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Exosome Diagnostic and Therapeutic Market, by Application
1.4.2 North America Exosome Diagnostic and Therapeutic Market, by Product
1.4.3 North America Exosome Diagnostic and Therapeutic Market, by End User
1.4.4 North America Exosome Diagnostic and Therapeutic Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Exosome Diagnostic and Therapeutic Market
Chapter 4. North America Exosome Diagnostic and Therapeutic Market by Application
4.1 North America Diagnostic Market by Country
4.2 North America Therapeutic Market by Country
Chapter 5. North America Exosome Diagnostic and Therapeutic Market by Product
5.1 North America Reagent Market by Country
5.2 North America Instrument Market by Country
5.3 North America Software Market by Country
Chapter 6. North America Exosome Diagnostic and Therapeutic Market by End User
6.1 North America Cancer Institute Market by Country
6.2 North America Hospital Market by Country
6.3 North America Diagnostic Center Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Exosome Diagnostic and Therapeutic Market by Country
7.1 US Exosome Diagnostic and Therapeutic Market
7.1.1 US Exosome Diagnostic and Therapeutic Market by Application
7.1.2 US Exosome Diagnostic and Therapeutic Market by Product
7.1.3 US Exosome Diagnostic and Therapeutic Market by End User
7.2 Canada Exosome Diagnostic and Therapeutic Market
7.2.1 Canada Exosome Diagnostic and Therapeutic Market by Application
7.2.2 Canada Exosome Diagnostic and Therapeutic Market by Product
7.2.3 Canada Exosome Diagnostic and Therapeutic Market by End User
7.3 Mexico Exosome Diagnostic and Therapeutic Market
7.3.1 Mexico Exosome Diagnostic and Therapeutic Market by Application
7.3.2 Mexico Exosome Diagnostic and Therapeutic Market by Product
7.3.3 Mexico Exosome Diagnostic and Therapeutic Market by End User
7.4 Rest of North America Exosome Diagnostic and Therapeutic Market
7.4.1 Rest of North America Exosome Diagnostic and Therapeutic Market by Application
7.4.2 Rest of North America Exosome Diagnostic and Therapeutic Market by Product
7.4.3 Rest of North America Exosome Diagnostic and Therapeutic Market by End User
Chapter 8. Company Profiles
8.1 Bio-Techne Corporation (Exosome Diagnostic, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.2 Qiagen N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Aethlon Medical, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expenses
8.5 Capricor Therapeutics, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.6 Malvern Panalytical Ltd. (Spectris plc)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.7 Nanosomix, Inc.
8.7.1 Company Overview
8.8 System Biosciences, LLC
8.8.1 Company Overview
8.9 NX Pharmagen, Inc. (NX Prenatal, Inc.)
8.9.1 Company Overview
Unique Offerings 